Annual EBITDA
$9.30B$163.00M-1.72%
Summary
- Current Value
- As of today, ELV annual EBITDA is $9.30B, down -1.72% on
- Historical Performance
- ELV annual EBITDA is up +0.76% over the past 3 years, and up +30.61% over the past 5 years
- All-Time High Comparison
- ELV annual EBITDA is currently -1.72% below its historical high of $9.46B set on
- 3-Year Low Comparison
- ELV annual EBITDA is +0.24% above its 3-year low of $9.28B reached on an earlier date
- Sector Comparison
- ELV annual EBITDA is higher than 98.81% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $9.30B | -1.7% | +0.8% | +30.6% | +16.9% | |
| Quarterly EBITDA | $1.79B | +5.3% | -30.4% | +157.3% | +38.7% | |
| TTM EBITDA | $8.64B | -11.1% | -9.2% | +10.3% | +1.4% | |
| Price | $374.87 | -2.7% | -22.4% | +14.8% | +489.9% | |
| PE Ratio | 15.33 | +1.9% | -23.0% | -15.9% | +66.8% | |
| Annual Revenue | $176.81B | +3.2% | +27.5% | +69.7% | +186.8% | |
| Annual EPS | $25.68 | +1.8% | +3.8% | +39.0% | +159.9% | |
| Annual EBIT | $7.90B | +2.5% | -0.3% | +32.1% | +6.8% | |
| Annual Net Income | $5.97B | -0.3% | -2.0% | +24.2% | +25.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.46B | -1.7% | |
| 5Y | $9.46B | -1.7% | |
| All | $9.46B | -1.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $9.28B | N/A | +0.2% |
| 5Y | $7.39B | N/A | +25.8% |
| All | $964.60M | +863.8% |
EBITDA History
FAQ
What is the current annual EBITDA of ELV?
As of today, ELV annual EBITDA is $9.30B
What is 1-year change in ELV annual EBITDA?
ELV annual EBITDA is down -1.72% year-over-year
What is 3-year change in ELV annual EBITDA?
ELV annual EBITDA is up +0.76% over the past 3 years
How far is ELV annual EBITDA from its all-time high?
ELV annual EBITDA is currently -1.72% below its historical high of $9.46B set on December 31, 2023
How does ELV annual EBITDA rank versus sector peers?
ELV annual EBITDA is higher than 98.81% of companies in Healthcare sector
When is ELV next annual earnings release?
The next annual earnings release for ELV is on
Quarterly EBITDA
$1.79B$879.00M-32.90%
Summary
- Current Value
- As of today, ELV quarterly EBITDA is $1.79B, down -32.90% on
- Historical Performance
- ELV quarterly EBITDA is up +5.35% year-over-year, and down -30.45% over the past 3 years
- All-Time High Comparison
- ELV quarterly EBITDA is currently -59.95% below its historical high of $4.48B set on
- 3-Year Low Comparison
- ELV quarterly EBITDA is +78.59% above its 3-year low of $1.00B reached on
- Sector Comparison
- ELV quarterly EBITDA is higher than 98.01% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.79B | -32.9% | +5.3% | -30.4% | +157.3% | |
| Annual EBITDA | $9.30B | – | -1.7% | +0.8% | +30.6% | |
| TTM EBITDA | $8.64B | +1.1% | -11.1% | -9.2% | +10.3% | |
| Price | $374.87 | +7.7% | -2.7% | -22.4% | +14.8% | |
| PE Ratio | 15.33 | +7.7% | +1.9% | -23.0% | -15.9% | |
| Quarterly Revenue | $50.71B | +1.9% | +12.3% | +27.0% | +62.8% | |
| Quarterly EPS | $5.32 | -31.1% | +21.9% | -19.7% | +508.6% | |
| Quarterly EBIT | $1.41B | -38.7% | +2.4% | -33.9% | +261.4% | |
| Quarterly Net Income | $1.19B | -31.9% | +17.8% | -25.7% | +434.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.17B | -43.4% | |
| 3Y | $3.32B | -46.0% | |
| 5Y | $3.32B | -46.0% | |
| All | $4.48B | -60.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.00B | N/A | +78.6% |
| 3Y | $1.00B | +78.6% | |
| 5Y | $901.00M | N/A | +99.0% |
| All | $215.20M | +733.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ELV?
As of today, ELV quarterly EBITDA is $1.79B
What is ELV quarterly EBITDA most recent change?
ELV quarterly EBITDA was down -32.90% on September 30, 2025
What is 1-year change in ELV quarterly EBITDA?
ELV quarterly EBITDA is up +5.35% year-over-year
How far is ELV quarterly EBITDA from its all-time high?
ELV quarterly EBITDA is currently -59.95% below its historical high of $4.48B set on December 31, 2009
How does ELV quarterly EBITDA rank versus sector peers?
ELV quarterly EBITDA is higher than 98.01% of companies in Healthcare sector
When is ELV next earnings release?
The next earnings release for ELV is on
TTM EBITDA
$8.64B$91.00M+1.06%
Summary
- Current Value
- As of today, ELV TTM EBITDA is $8.64B, up +1.06% on
- Historical Performance
- ELV TTM EBITDA is down -11.10% year-over-year, and down -9.23% over the past 3 years
- All-Time High Comparison
- ELV TTM EBITDA is currently -14.43% below its historical high of $10.10B set on
- 3-Year Low Comparison
- ELV TTM EBITDA is +1.06% above its 3-year low of $8.55B reached on
- Sector Comparison
- ELV TTM EBITDA is higher than 98.19% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $8.64B | +1.1% | -11.1% | -9.2% | +10.3% | |
| Annual EBITDA | $9.30B | – | -1.7% | +0.8% | +30.6% | |
| Quarterly EBITDA | $1.79B | -32.9% | +5.3% | -30.4% | +157.3% | |
| Price | $374.87 | +7.7% | -2.7% | -22.4% | +14.8% | |
| PE Ratio | 15.33 | +7.7% | +1.9% | -23.0% | -15.9% | |
| TTM Revenue | $194.82B | +2.9% | +12.0% | +27.1% | +65.9% | |
| TTM EPS | $24.45 | +4.1% | -10.9% | -3.3% | +26.4% | |
| TTM EBIT | $7.10B | +0.5% | -14.4% | -10.7% | +5.6% | |
| TTM Net Income | $5.53B | +3.4% | -13.5% | -9.9% | +11.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.30B | N/A | -7.1% |
| 3Y | $10.10B | -14.4% | |
| 5Y | $10.10B | -14.4% | |
| All | $10.10B | -14.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $8.55B | +1.1% | |
| 3Y | $8.55B | +1.1% | |
| 5Y | $6.72B | +28.6% | |
| All | $215.20M | +3914.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ELV?
As of today, ELV TTM EBITDA is $8.64B
What is ELV TTM EBITDA most recent change?
ELV TTM EBITDA was up +1.06% on September 30, 2025
What is 1-year change in ELV TTM EBITDA?
ELV TTM EBITDA is down -11.10% year-over-year
How far is ELV TTM EBITDA from its all-time high?
ELV TTM EBITDA is currently -14.43% below its historical high of $10.10B set on June 30, 2024
How does ELV TTM EBITDA rank versus sector peers?
ELV TTM EBITDA is higher than 98.19% of companies in Healthcare sector
When is ELV next earnings release?
The next earnings release for ELV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ELV Official Website www.elevancehealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1156039/000115603925000136/0001156039-25-000136-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1156039/000115603925000010/0001156039-25-000010-index.htm
- ELV Profile on Yahoo Finance finance.yahoo.com/quote/ELV
- ELV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/elv